| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Irritable Bowel Syndrome | 65 | 2023 | 208 | 19.900 |
Why?
|
| Abdominal Pain | 61 | 2023 | 369 | 11.590 |
Why?
|
| Gastroparesis | 27 | 2023 | 72 | 8.370 |
Why?
|
| Gastrointestinal Diseases | 33 | 2023 | 589 | 7.750 |
Why?
|
| Dyspepsia | 9 | 2023 | 103 | 3.710 |
Why?
|
| Constipation | 14 | 2023 | 177 | 3.640 |
Why?
|
| Gastrointestinal Microbiome | 15 | 2023 | 907 | 3.060 |
Why?
|
| Feces | 26 | 2023 | 770 | 2.830 |
Why?
|
| Gastroenterology | 9 | 2022 | 195 | 2.430 |
Why?
|
| Intestinal Mucosa | 21 | 2019 | 1081 | 2.350 |
Why?
|
| Gastric Emptying | 21 | 2023 | 94 | 2.310 |
Why?
|
| Probiotics | 8 | 2022 | 228 | 2.300 |
Why?
|
| Child | 116 | 2023 | 29154 | 2.280 |
Why?
|
| Plant Oils | 4 | 2022 | 37 | 2.170 |
Why?
|
| Colic | 3 | 2022 | 14 | 1.870 |
Why?
|
| Malabsorption Syndromes | 6 | 2018 | 55 | 1.810 |
Why?
|
| Infant, Premature | 22 | 2021 | 787 | 1.790 |
Why?
|
| Psyllium | 3 | 2023 | 14 | 1.750 |
Why?
|
| Somatoform Disorders | 5 | 2021 | 61 | 1.630 |
Why?
|
| Surveys and Questionnaires | 27 | 2023 | 5687 | 1.590 |
Why?
|
| Enteral Nutrition | 13 | 2023 | 316 | 1.590 |
Why?
|
| Gastroesophageal Reflux | 5 | 2023 | 334 | 1.580 |
Why?
|
| Intestine, Small | 17 | 2021 | 499 | 1.570 |
Why?
|
| Dietary Carbohydrates | 10 | 2018 | 134 | 1.520 |
Why?
|
| Quality of Life | 25 | 2023 | 4532 | 1.470 |
Why?
|
| Diarrhea | 10 | 2020 | 686 | 1.470 |
Why?
|
| Infant Nutritional Physiological Phenomena | 11 | 2020 | 182 | 1.460 |
Why?
|
| Dietary Fiber | 6 | 2023 | 123 | 1.450 |
Why?
|
| Menthol | 2 | 2021 | 9 | 1.370 |
Why?
|
| Severity of Illness Index | 21 | 2021 | 4320 | 1.330 |
Why?
|
| Lactulose | 13 | 2019 | 38 | 1.310 |
Why?
|
| Parenteral Nutrition | 14 | 2023 | 207 | 1.280 |
Why?
|
| Humans | 238 | 2023 | 261506 | 1.270 |
Why?
|
| Gastrointestinal Tract | 8 | 2023 | 324 | 1.230 |
Why?
|
| Intestinal Absorption | 16 | 2014 | 211 | 1.190 |
Why?
|
| Vomiting | 9 | 2023 | 354 | 1.190 |
Why?
|
| Adolescent | 60 | 2023 | 31252 | 1.160 |
Why?
|
| Nausea | 12 | 2023 | 525 | 1.130 |
Why?
|
| Symptom Assessment | 4 | 2021 | 267 | 1.100 |
Why?
|
| Anxiety | 13 | 2023 | 1179 | 1.090 |
Why?
|
| Stomach | 4 | 2021 | 387 | 1.090 |
Why?
|
| Pediatrics | 11 | 2020 | 1141 | 1.080 |
Why?
|
| Parenteral Nutrition, Total | 18 | 2005 | 140 | 1.060 |
Why?
|
| Inflammatory Bowel Diseases | 5 | 2017 | 363 | 1.050 |
Why?
|
| Fructans | 3 | 2021 | 14 | 1.030 |
Why?
|
| Microbiota | 7 | 2023 | 547 | 1.020 |
Why?
|
| Defecation | 6 | 2023 | 58 | 1.010 |
Why?
|
| Eating | 3 | 2022 | 421 | 1.000 |
Why?
|
| Diet | 11 | 2023 | 1440 | 0.950 |
Why?
|
| Female | 125 | 2023 | 141928 | 0.950 |
Why?
|
| Colonic Diseases, Functional | 4 | 2023 | 16 | 0.950 |
Why?
|
| Permeability | 9 | 2019 | 167 | 0.940 |
Why?
|
| Nutritional Sciences | 2 | 2015 | 68 | 0.920 |
Why?
|
| Male | 113 | 2023 | 123000 | 0.910 |
Why?
|
| Infant Food | 8 | 2018 | 89 | 0.910 |
Why?
|
| Child, Preschool | 51 | 2023 | 16273 | 0.890 |
Why?
|
| Gastrointestinal Motility | 3 | 2021 | 92 | 0.850 |
Why?
|
| Digestion | 4 | 2018 | 55 | 0.850 |
Why?
|
| Mannitol | 8 | 2016 | 54 | 0.820 |
Why?
|
| Fermentation | 6 | 2022 | 60 | 0.820 |
Why?
|
| Insulins | 1 | 2021 | 18 | 0.810 |
Why?
|
| Reflex | 1 | 2021 | 68 | 0.800 |
Why?
|
| Meals | 2 | 2022 | 66 | 0.790 |
Why?
|
| Gastrointestinal Agents | 7 | 2014 | 108 | 0.790 |
Why?
|
| Intestinal Diseases | 6 | 2016 | 121 | 0.790 |
Why?
|
| Infant, Newborn | 46 | 2022 | 8223 | 0.780 |
Why?
|
| Esophagus | 2 | 2015 | 553 | 0.780 |
Why?
|
| Double-Blind Method | 15 | 2023 | 2588 | 0.770 |
Why?
|
| beta-Defensins | 1 | 2020 | 30 | 0.770 |
Why?
|
| Glucose | 20 | 2003 | 1248 | 0.770 |
Why?
|
| Neuroimmunomodulation | 2 | 2018 | 66 | 0.760 |
Why?
|
| Starch | 2 | 2018 | 47 | 0.750 |
Why?
|
| Oligosaccharides | 7 | 2022 | 110 | 0.740 |
Why?
|
| alpha-Glucosidases | 5 | 2018 | 55 | 0.730 |
Why?
|
| Monosaccharides | 5 | 2022 | 24 | 0.720 |
Why?
|
| Mentha piperita | 4 | 2022 | 10 | 0.720 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2016 | 174 | 0.710 |
Why?
|
| Sus scrofa | 1 | 2020 | 169 | 0.700 |
Why?
|
| Joint Instability | 1 | 2020 | 88 | 0.700 |
Why?
|
| Lactose | 6 | 2009 | 63 | 0.680 |
Why?
|
| Catastrophization | 1 | 2018 | 11 | 0.680 |
Why?
|
| Dietary Supplements | 4 | 2019 | 558 | 0.670 |
Why?
|
| Leukocyte L1 Antigen Complex | 4 | 2022 | 17 | 0.670 |
Why?
|
| Chromogranins | 1 | 2018 | 84 | 0.660 |
Why?
|
| RNA, Ribosomal, 16S | 11 | 2022 | 490 | 0.650 |
Why?
|
| Autonomic Nervous System | 1 | 2018 | 72 | 0.650 |
Why?
|
| Hydrogen | 6 | 2017 | 58 | 0.630 |
Why?
|
| Radionuclide Imaging | 9 | 2023 | 660 | 0.630 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2015 | 73 | 0.620 |
Why?
|
| Chronic Pain | 1 | 2021 | 238 | 0.610 |
Why?
|
| Pain Threshold | 3 | 2016 | 130 | 0.600 |
Why?
|
| Models, Animal | 1 | 2020 | 664 | 0.600 |
Why?
|
| Sex Characteristics | 1 | 2019 | 417 | 0.590 |
Why?
|
| Health Communication | 1 | 2017 | 37 | 0.580 |
Why?
|
| Cholestasis | 6 | 2007 | 203 | 0.580 |
Why?
|
| Cisapride | 4 | 2000 | 7 | 0.580 |
Why?
|
| Food Intolerance | 1 | 2016 | 2 | 0.580 |
Why?
|
| Infant | 41 | 2021 | 13310 | 0.580 |
Why?
|
| Lactase | 10 | 2010 | 38 | 0.570 |
Why?
|
| Food Hypersensitivity | 3 | 2016 | 135 | 0.570 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 33 | 0.560 |
Why?
|
| Catheterization, Central Venous | 7 | 2011 | 354 | 0.560 |
Why?
|
| Bottle Feeding | 6 | 2007 | 36 | 0.550 |
Why?
|
| Disaccharides | 4 | 2022 | 31 | 0.530 |
Why?
|
| Health Records, Personal | 1 | 2015 | 20 | 0.530 |
Why?
|
| Diet, Carbohydrate-Restricted | 3 | 2021 | 20 | 0.530 |
Why?
|
| Parents | 11 | 2021 | 998 | 0.520 |
Why?
|
| Endoscopy, Digestive System | 3 | 2013 | 202 | 0.520 |
Why?
|
| Cytokines | 3 | 2020 | 2809 | 0.510 |
Why?
|
| Short Bowel Syndrome | 3 | 2020 | 60 | 0.510 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 169 | 0.500 |
Why?
|
| Prospective Studies | 19 | 2022 | 12873 | 0.500 |
Why?
|
| Self Concept | 1 | 2016 | 211 | 0.500 |
Why?
|
| Glutamine | 10 | 2001 | 299 | 0.500 |
Why?
|
| Deglutition | 2 | 2015 | 171 | 0.500 |
Why?
|
| Animals, Newborn | 13 | 2020 | 1338 | 0.500 |
Why?
|
| Antiemetics | 1 | 2015 | 125 | 0.480 |
Why?
|
| Esophagitis, Peptic | 1 | 2014 | 36 | 0.480 |
Why?
|
| Breath Tests | 8 | 2017 | 177 | 0.480 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2012 | 67 | 0.480 |
Why?
|
| Intestines | 6 | 2015 | 686 | 0.480 |
Why?
|
| Magnetic Resonance Spectroscopy | 14 | 2001 | 624 | 0.470 |
Why?
|
| Nutritional Status | 3 | 2015 | 337 | 0.470 |
Why?
|
| Brain | 8 | 2014 | 4113 | 0.470 |
Why?
|
| Colitis, Ulcerative | 1 | 2016 | 268 | 0.470 |
Why?
|
| Celiac Disease | 2 | 2013 | 75 | 0.460 |
Why?
|
| Nociceptive Pain | 1 | 2013 | 8 | 0.460 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2014 | 375 | 0.460 |
Why?
|
| Crohn Disease | 2 | 2016 | 351 | 0.460 |
Why?
|
| Disaccharidases | 7 | 1994 | 20 | 0.450 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 441 | 0.450 |
Why?
|
| Prevalence | 7 | 2021 | 3260 | 0.450 |
Why?
|
| beta-Galactosidase | 9 | 2002 | 211 | 0.440 |
Why?
|
| Gallbladder | 2 | 2012 | 69 | 0.440 |
Why?
|
| Micronutrients | 4 | 2022 | 75 | 0.440 |
Why?
|
| Insulin | 13 | 2002 | 1454 | 0.440 |
Why?
|
| Biliary Dyskinesia | 1 | 2012 | 4 | 0.440 |
Why?
|
| Methane | 3 | 2017 | 19 | 0.430 |
Why?
|
| Milk, Human | 5 | 2001 | 277 | 0.430 |
Why?
|
| Pain Measurement | 6 | 2016 | 953 | 0.430 |
Why?
|
| Gallbladder Diseases | 1 | 2012 | 43 | 0.430 |
Why?
|
| Bacteria | 4 | 2019 | 611 | 0.420 |
Why?
|
| Zinc | 5 | 2016 | 188 | 0.420 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 4314 | 0.420 |
Why?
|
| Pain | 3 | 2017 | 1658 | 0.410 |
Why?
|
| Glutamic Acid | 8 | 2001 | 309 | 0.410 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 447 | 0.390 |
Why?
|
| Interleukin-10 | 1 | 2014 | 478 | 0.390 |
Why?
|
| Dietary Sucrose | 2 | 2012 | 42 | 0.390 |
Why?
|
| Depression | 6 | 2021 | 1715 | 0.380 |
Why?
|
| Gastrointestinal Contents | 1 | 2010 | 12 | 0.380 |
Why?
|
| Pilot Projects | 6 | 2023 | 2803 | 0.380 |
Why?
|
| Palatine Tonsil | 1 | 2010 | 53 | 0.380 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 1085 | 0.380 |
Why?
|
| Growth Disorders | 3 | 2019 | 218 | 0.370 |
Why?
|
| Teaching | 1 | 2012 | 243 | 0.370 |
Why?
|
| Age Factors | 12 | 2016 | 5377 | 0.370 |
Why?
|
| Gastritis | 1 | 2014 | 373 | 0.370 |
Why?
|
| Photography | 1 | 2011 | 139 | 0.360 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 122 | 0.360 |
Why?
|
| Gastrointestinal Transit | 3 | 2020 | 26 | 0.360 |
Why?
|
| Case-Control Studies | 13 | 2021 | 6100 | 0.360 |
Why?
|
| Aspirin | 1 | 2013 | 455 | 0.350 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 521 | 0.350 |
Why?
|
| Metagenome | 5 | 2015 | 176 | 0.340 |
Why?
|
| Citric Acid Cycle | 2 | 2001 | 86 | 0.340 |
Why?
|
| Infant, Premature, Diseases | 5 | 2005 | 245 | 0.340 |
Why?
|
| Clostridium Infections | 2 | 2023 | 252 | 0.340 |
Why?
|
| Child Development | 5 | 2019 | 255 | 0.330 |
Why?
|
| Child Nutrition Disorders | 2 | 2016 | 77 | 0.330 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 1303 | 0.330 |
Why?
|
| Ammonia | 5 | 2001 | 88 | 0.330 |
Why?
|
| Precision Medicine | 1 | 2016 | 1154 | 0.330 |
Why?
|
| Diarrhea, Infantile | 6 | 1991 | 43 | 0.330 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 390 | 0.320 |
Why?
|
| Fat Emulsions, Intravenous | 7 | 2003 | 70 | 0.320 |
Why?
|
| Hydrocortisone | 4 | 2015 | 388 | 0.320 |
Why?
|
| Referral and Consultation | 2 | 2017 | 899 | 0.320 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2008 | 31 | 0.320 |
Why?
|
| Education, Medical | 1 | 2012 | 331 | 0.320 |
Why?
|
| Primary Health Care | 2 | 2017 | 787 | 0.310 |
Why?
|
| Growth | 2 | 2012 | 117 | 0.310 |
Why?
|
| Sex Factors | 4 | 2020 | 2139 | 0.300 |
Why?
|
| Lactobacillus | 2 | 2015 | 58 | 0.300 |
Why?
|
| Sucking Behavior | 3 | 2007 | 20 | 0.300 |
Why?
|
| Treatment Outcome | 19 | 2023 | 32848 | 0.300 |
Why?
|
| Stress, Psychological | 6 | 2017 | 1000 | 0.300 |
Why?
|
| Placebos | 3 | 2017 | 437 | 0.300 |
Why?
|
| Glutamates | 5 | 1992 | 130 | 0.300 |
Why?
|
| Gestational Age | 10 | 2010 | 1069 | 0.300 |
Why?
|
| Inflammation | 4 | 2014 | 2522 | 0.290 |
Why?
|
| Nitrogen | 6 | 1995 | 162 | 0.290 |
Why?
|
| Diabetes Complications | 2 | 2019 | 305 | 0.290 |
Why?
|
| Curriculum | 1 | 2012 | 860 | 0.290 |
Why?
|
| Swine, Miniature | 13 | 1997 | 67 | 0.280 |
Why?
|
| Glycogen | 4 | 1996 | 80 | 0.280 |
Why?
|
| Malawi | 9 | 2019 | 378 | 0.280 |
Why?
|
| Steroids | 1 | 2008 | 356 | 0.280 |
Why?
|
| Vitamins | 5 | 2016 | 157 | 0.280 |
Why?
|
| Infant Formula | 2 | 2022 | 91 | 0.270 |
Why?
|
| Albendazole | 2 | 2016 | 28 | 0.270 |
Why?
|
| Adult | 39 | 2023 | 77950 | 0.270 |
Why?
|
| Liver Diseases | 2 | 2020 | 574 | 0.260 |
Why?
|
| Malnutrition | 3 | 2019 | 218 | 0.260 |
Why?
|
| Blood Specimen Collection | 2 | 1998 | 93 | 0.260 |
Why?
|
| Gastroenteritis | 1 | 2008 | 300 | 0.260 |
Why?
|
| Dysbiosis | 2 | 2018 | 134 | 0.260 |
Why?
|
| Sleep Wake Disorders | 2 | 2021 | 348 | 0.260 |
Why?
|
| Cross-Over Studies | 2 | 2017 | 460 | 0.250 |
Why?
|
| Breast Feeding | 3 | 2006 | 239 | 0.250 |
Why?
|
| Retrospective Studies | 13 | 2023 | 37905 | 0.250 |
Why?
|
| Heart Rate | 3 | 2016 | 737 | 0.250 |
Why?
|
| Biomarkers | 8 | 2020 | 5047 | 0.240 |
Why?
|
| Cerebral Cortex | 3 | 2019 | 621 | 0.240 |
Why?
|
| Decontamination | 1 | 2023 | 16 | 0.240 |
Why?
|
| Smoking | 1 | 2013 | 2440 | 0.240 |
Why?
|
| Oryza | 2 | 1995 | 34 | 0.230 |
Why?
|
| Health Care Costs | 1 | 2009 | 674 | 0.230 |
Why?
|
| Digestive System | 2 | 2002 | 114 | 0.230 |
Why?
|
| Self Report | 3 | 2016 | 756 | 0.230 |
Why?
|
| Swine | 18 | 1997 | 1541 | 0.220 |
Why?
|
| Hydrochloric Acid | 2 | 1995 | 19 | 0.220 |
Why?
|
| Cattle | 2 | 2022 | 783 | 0.220 |
Why?
|
| Trans Fatty Acids | 1 | 2022 | 10 | 0.220 |
Why?
|
| Hypersensitivity | 2 | 2015 | 216 | 0.220 |
Why?
|
| Animals | 36 | 2022 | 59536 | 0.220 |
Why?
|
| Biomedical Research | 1 | 2010 | 806 | 0.220 |
Why?
|
| Proteome | 2 | 2019 | 561 | 0.220 |
Why?
|
| Weight Gain | 5 | 2021 | 464 | 0.210 |
Why?
|
| Ileum | 3 | 1992 | 165 | 0.210 |
Why?
|
| Analysis of Variance | 6 | 2013 | 2307 | 0.210 |
Why?
|
| Isoflavones | 1 | 2022 | 72 | 0.210 |
Why?
|
| Bacteroidetes | 1 | 2022 | 24 | 0.210 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 6009 | 0.210 |
Why?
|
| Food, Fortified | 2 | 2000 | 95 | 0.210 |
Why?
|
| Attitude to Health | 2 | 2015 | 465 | 0.210 |
Why?
|
| Phosphates | 4 | 1996 | 187 | 0.210 |
Why?
|
| Biopsy | 4 | 2015 | 3443 | 0.200 |
Why?
|
| Infant Nutrition Disorders | 2 | 2019 | 30 | 0.200 |
Why?
|
| Domperidone | 1 | 2021 | 6 | 0.200 |
Why?
|
| Catecholamines | 1 | 2001 | 101 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2016 | 1546 | 0.200 |
Why?
|
| Recurrence | 6 | 2022 | 4758 | 0.200 |
Why?
|
| Trefoil Factor-3 | 2 | 2018 | 10 | 0.190 |
Why?
|
| Young Adult | 12 | 2023 | 21445 | 0.190 |
Why?
|
| Contraceptive Agents | 1 | 2020 | 17 | 0.190 |
Why?
|
| Glycoside Hydrolases | 2 | 2012 | 37 | 0.190 |
Why?
|
| Mood Disorders | 1 | 2021 | 163 | 0.190 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 134 | 0.190 |
Why?
|
| Bifidobacterium | 1 | 2020 | 64 | 0.190 |
Why?
|
| Urine | 2 | 2018 | 143 | 0.180 |
Why?
|
| Tryptophan | 2 | 2023 | 127 | 0.180 |
Why?
|
| Lactates | 7 | 1996 | 112 | 0.180 |
Why?
|
| Coinfection | 1 | 2022 | 189 | 0.180 |
Why?
|
| Sucrose | 3 | 2010 | 64 | 0.180 |
Why?
|
| RNA, Messenger | 3 | 2016 | 6150 | 0.180 |
Why?
|
| Energy Intake | 6 | 2014 | 515 | 0.180 |
Why?
|
| Sprue, Tropical | 1 | 2019 | 4 | 0.180 |
Why?
|
| Self-Management | 1 | 2021 | 89 | 0.180 |
Why?
|
| Bacterial Infections | 2 | 2022 | 479 | 0.170 |
Why?
|
| Pain Perception | 1 | 2019 | 13 | 0.170 |
Why?
|
| Respiratory Sinus Arrhythmia | 1 | 2018 | 8 | 0.170 |
Why?
|
| Tertiary Care Centers | 3 | 2021 | 403 | 0.170 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 1999 | 200 | 0.170 |
Why?
|
| Muramidase | 1 | 2019 | 110 | 0.170 |
Why?
|
| Feeding Behavior | 4 | 2010 | 808 | 0.170 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1999 | 78 | 0.170 |
Why?
|
| Research | 1 | 2002 | 415 | 0.170 |
Why?
|
| Cross Infection | 1 | 2023 | 544 | 0.170 |
Why?
|
| Colon | 2 | 2015 | 670 | 0.170 |
Why?
|
| Sleep | 3 | 2021 | 413 | 0.170 |
Why?
|
| Rural Population | 4 | 2016 | 281 | 0.170 |
Why?
|
| United States | 7 | 2021 | 15433 | 0.170 |
Why?
|
| Corpus Striatum | 1 | 2019 | 104 | 0.170 |
Why?
|
| Polymers | 2 | 2022 | 223 | 0.170 |
Why?
|
| Immune System | 1 | 2020 | 279 | 0.160 |
Why?
|
| Sugar Alcohols | 1 | 2018 | 9 | 0.160 |
Why?
|
| Lactoferrin | 1 | 2019 | 81 | 0.160 |
Why?
|
| Gray Matter | 1 | 2019 | 63 | 0.160 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 116 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2001 | 629 | 0.160 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 4892 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 246 | 0.160 |
Why?
|
| Blood Glucose | 10 | 2001 | 1244 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 6 | 2000 | 181 | 0.160 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 363 | 0.160 |
Why?
|
| Anxiety Disorders | 2 | 2021 | 666 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 446 | 0.160 |
Why?
|
| Nutritive Value | 1 | 2018 | 96 | 0.160 |
Why?
|
| Chronic Disease | 6 | 2013 | 1819 | 0.160 |
Why?
|
| Genome-Wide Association Study | 2 | 2023 | 2265 | 0.160 |
Why?
|
| Diet Therapy | 1 | 2018 | 52 | 0.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2014 | 461 | 0.160 |
Why?
|
| Time Factors | 9 | 2015 | 12926 | 0.160 |
Why?
|
| Physical Exertion | 2 | 1996 | 113 | 0.160 |
Why?
|
| Esophageal Stenosis | 2 | 2006 | 83 | 0.150 |
Why?
|
| Statistics, Nonparametric | 2 | 2019 | 980 | 0.150 |
Why?
|
| Osmolar Concentration | 3 | 2006 | 204 | 0.150 |
Why?
|
| Muscles | 4 | 1994 | 416 | 0.150 |
Why?
|
| Aminoglycosides | 1 | 1998 | 220 | 0.150 |
Why?
|
| Veins | 1 | 1998 | 157 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2021 | 410 | 0.150 |
Why?
|
| Cyclosporine | 1 | 1998 | 278 | 0.150 |
Why?
|
| Acetates | 5 | 2001 | 105 | 0.150 |
Why?
|
| Connectome | 1 | 2019 | 112 | 0.150 |
Why?
|
| Dietary Proteins | 3 | 2015 | 241 | 0.150 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2020 | 223 | 0.150 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 2594 | 0.150 |
Why?
|
| Medical Records | 2 | 2009 | 415 | 0.140 |
Why?
|
| Visceral Pain | 1 | 2016 | 9 | 0.140 |
Why?
|
| Polysaccharides | 1 | 2017 | 197 | 0.140 |
Why?
|
| Vancomycin | 1 | 1998 | 273 | 0.140 |
Why?
|
| Enteritis | 1 | 2016 | 65 | 0.140 |
Why?
|
| Puberty | 1 | 2016 | 104 | 0.140 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 1986 | 111 | 0.140 |
Why?
|
| Internet | 2 | 2018 | 706 | 0.140 |
Why?
|
| Specimen Handling | 2 | 2015 | 299 | 0.140 |
Why?
|
| Follow-Up Studies | 7 | 2017 | 14889 | 0.140 |
Why?
|
| Body Composition | 2 | 1993 | 595 | 0.140 |
Why?
|
| Administration, Oral | 3 | 2015 | 1544 | 0.140 |
Why?
|
| Nerve Net | 1 | 2019 | 257 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 309 | 0.140 |
Why?
|
| Sucrase-Isomaltase Complex | 2 | 2012 | 31 | 0.130 |
Why?
|
| Silicone Elastomers | 1 | 1995 | 49 | 0.130 |
Why?
|
| Mental Recall | 2 | 2015 | 171 | 0.130 |
Why?
|
| Biodiversity | 1 | 2015 | 91 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 2 | 1985 | 97 | 0.130 |
Why?
|
| Food, Formulated | 2 | 1999 | 50 | 0.120 |
Why?
|
| Rome | 1 | 2014 | 7 | 0.120 |
Why?
|
| Environmental Illness | 1 | 2014 | 2 | 0.120 |
Why?
|
| Risk Factors | 8 | 2015 | 17523 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 860 | 0.120 |
Why?
|
| Vagus Nerve | 2 | 2012 | 63 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2021 | 901 | 0.120 |
Why?
|
| Hydrogen-Ion Concentration | 6 | 1999 | 585 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2015 | 700 | 0.120 |
Why?
|
| Saliva | 1 | 2014 | 231 | 0.120 |
Why?
|
| Amino Acids | 4 | 2003 | 728 | 0.110 |
Why?
|
| Serologic Tests | 1 | 2013 | 137 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 1054 | 0.110 |
Why?
|
| Physical Stimulation | 1 | 2013 | 112 | 0.110 |
Why?
|
| Middle Aged | 16 | 2021 | 86204 | 0.110 |
Why?
|
| Food | 1 | 2013 | 146 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1987 | 621 | 0.110 |
Why?
|
| Enteric Nervous System | 1 | 2012 | 36 | 0.110 |
Why?
|
| Comorbidity | 2 | 2023 | 2352 | 0.110 |
Why?
|
| Prebiotics | 1 | 2012 | 34 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2017 | 492 | 0.110 |
Why?
|
| Appetite | 1 | 1992 | 73 | 0.110 |
Why?
|
| Lactose Intolerance | 2 | 2005 | 11 | 0.110 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 249 | 0.110 |
Why?
|
| Carbohydrate Metabolism, Inborn Errors | 1 | 2012 | 45 | 0.110 |
Why?
|
| Blood | 1 | 1993 | 156 | 0.110 |
Why?
|
| Jejunum | 5 | 1994 | 216 | 0.110 |
Why?
|
| Hospitalization | 1 | 2021 | 2083 | 0.110 |
Why?
|
| Reye Syndrome | 1 | 1992 | 15 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 2992 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2021 | 9244 | 0.110 |
Why?
|
| Catheters, Indwelling | 3 | 2011 | 374 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2012 | 94 | 0.110 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 162 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2014 | 298 | 0.100 |
Why?
|
| Mexico | 1 | 2012 | 259 | 0.100 |
Why?
|
| Problem-Based Learning | 1 | 2012 | 78 | 0.100 |
Why?
|
| Kinetics | 9 | 1997 | 2049 | 0.100 |
Why?
|
| Metagenomics | 1 | 2012 | 115 | 0.100 |
Why?
|
| Enterococcus | 1 | 2012 | 59 | 0.100 |
Why?
|
| Fecal Microbiota Transplantation | 2 | 2023 | 149 | 0.100 |
Why?
|
| Models, Biological | 6 | 1998 | 3254 | 0.100 |
Why?
|
| Reinforcement, Verbal | 1 | 2011 | 3 | 0.100 |
Why?
|
| Cholecystectomy | 1 | 2012 | 107 | 0.100 |
Why?
|
| Perception | 1 | 2013 | 350 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2014 | 314 | 0.100 |
Why?
|
| Canada | 1 | 2012 | 429 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 598 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1992 | 154 | 0.100 |
Why?
|
| Piperidines | 1 | 1996 | 1035 | 0.100 |
Why?
|
| Water | 3 | 2022 | 361 | 0.100 |
Why?
|
| Hyperalgesia | 1 | 2013 | 238 | 0.100 |
Why?
|
| Texas | 3 | 2017 | 6311 | 0.100 |
Why?
|
| Carbon Isotopes | 6 | 2001 | 333 | 0.100 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2014 | 709 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2014 | 552 | 0.100 |
Why?
|
| Observational Studies as Topic | 2 | 2022 | 140 | 0.090 |
Why?
|
| Smad4 Protein | 1 | 2012 | 196 | 0.090 |
Why?
|
| Nutrition Disorders | 1 | 1990 | 57 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 1996 | 1270 | 0.090 |
Why?
|
| Bacteremia | 2 | 1994 | 689 | 0.090 |
Why?
|
| Rats | 7 | 2001 | 6086 | 0.090 |
Why?
|
| Hypertrophy | 1 | 2010 | 162 | 0.090 |
Why?
|
| Minerals | 2 | 2016 | 71 | 0.090 |
Why?
|
| Carbon Dioxide | 5 | 1985 | 313 | 0.090 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 294 | 0.090 |
Why?
|
| Carbohydrates | 1 | 1990 | 68 | 0.090 |
Why?
|
| Zollinger-Ellison Syndrome | 1 | 1989 | 7 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2012 | 436 | 0.090 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 79 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2011 | 163 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2001 | 2063 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2012 | 362 | 0.090 |
Why?
|
| Data Collection | 1 | 2012 | 620 | 0.090 |
Why?
|
| Glucagon | 6 | 1996 | 196 | 0.090 |
Why?
|
| Copper | 2 | 1994 | 165 | 0.090 |
Why?
|
| Rifamycins | 1 | 2009 | 32 | 0.090 |
Why?
|
| Faculty, Medical | 1 | 2012 | 289 | 0.090 |
Why?
|
| Prognosis | 3 | 2017 | 21713 | 0.090 |
Why?
|
| Nutritional Requirements | 4 | 2003 | 185 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2012 | 651 | 0.080 |
Why?
|
| Fructose | 1 | 2009 | 72 | 0.080 |
Why?
|
| Colostrum | 3 | 1994 | 49 | 0.080 |
Why?
|
| Colitis | 1 | 2012 | 340 | 0.080 |
Why?
|
| Observer Variation | 1 | 2010 | 671 | 0.080 |
Why?
|
| Fibrinolytic Agents | 1 | 2011 | 324 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 1987 | 571 | 0.080 |
Why?
|
| Iodoacetates | 1 | 1987 | 7 | 0.080 |
Why?
|
| Antimycin A | 1 | 1987 | 13 | 0.080 |
Why?
|
| Pain Management | 1 | 2014 | 668 | 0.080 |
Why?
|
| Absorption | 2 | 1999 | 81 | 0.080 |
Why?
|
| Complementary Therapies | 1 | 2009 | 126 | 0.080 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 1323 | 0.080 |
Why?
|
| Phylogeny | 3 | 2018 | 826 | 0.080 |
Why?
|
| Healthy Volunteers | 2 | 2020 | 187 | 0.080 |
Why?
|
| Endoscopy | 2 | 2008 | 479 | 0.080 |
Why?
|
| Phosphorus | 4 | 1994 | 65 | 0.080 |
Why?
|
| Methylprednisolone | 1 | 2008 | 193 | 0.080 |
Why?
|
| Pancreas | 1 | 1991 | 718 | 0.080 |
Why?
|
| Mucous Membrane | 1 | 2008 | 271 | 0.070 |
Why?
|
| Nitrogen Isotopes | 2 | 1998 | 60 | 0.070 |
Why?
|
| Protein Deficiency | 1 | 1986 | 20 | 0.070 |
Why?
|
| Glucans | 1 | 1986 | 18 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2009 | 3719 | 0.070 |
Why?
|
| Psychotherapy | 1 | 2009 | 247 | 0.070 |
Why?
|
| Gastrectomy | 1 | 1989 | 451 | 0.070 |
Why?
|
| Sucrase | 3 | 1991 | 26 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2023 | 5539 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2019 | 218 | 0.070 |
Why?
|
| Liver | 5 | 1994 | 2961 | 0.070 |
Why?
|
| Antidepressive Agents | 1 | 2009 | 332 | 0.070 |
Why?
|
| Splanchnic Circulation | 1 | 1986 | 53 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 5159 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2012 | 1145 | 0.070 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2006 | 66 | 0.070 |
Why?
|
| Spectrum Analysis | 1 | 1986 | 139 | 0.070 |
Why?
|
| Burns, Chemical | 1 | 2006 | 34 | 0.070 |
Why?
|
| Exercise | 1 | 1994 | 1183 | 0.070 |
Why?
|
| Societies, Medical | 1 | 2012 | 1335 | 0.070 |
Why?
|
| Taurine | 1 | 2005 | 23 | 0.070 |
Why?
|
| Sweetening Agents | 1 | 2005 | 33 | 0.070 |
Why?
|
| Energy Metabolism | 4 | 1995 | 992 | 0.070 |
Why?
|
| Arteriovenous Malformations | 1 | 1986 | 70 | 0.070 |
Why?
|
| Aminopyrine | 1 | 1985 | 5 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 918 | 0.070 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1985 | 19 | 0.070 |
Why?
|
| Creatinine | 2 | 2012 | 531 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2010 | 661 | 0.070 |
Why?
|
| Cysteine | 2 | 2000 | 214 | 0.070 |
Why?
|
| Sincalide | 1 | 2005 | 37 | 0.070 |
Why?
|
| Splenic Neoplasms | 1 | 1986 | 119 | 0.070 |
Why?
|
| Mitomycin | 1 | 2006 | 208 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 1986 | 124 | 0.060 |
Why?
|
| Aged | 7 | 2023 | 70117 | 0.060 |
Why?
|
| Models, Theoretical | 2 | 2001 | 785 | 0.060 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 558 | 0.060 |
Why?
|
| Hemangioma | 1 | 1986 | 154 | 0.060 |
Why?
|
| Mothers | 1 | 2007 | 410 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2009 | 1945 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2012 | 1270 | 0.060 |
Why?
|
| Milk | 3 | 2013 | 120 | 0.060 |
Why?
|
| Tropical Medicine | 1 | 2005 | 105 | 0.060 |
Why?
|
| Lactase-Phlorizin Hydrolase | 2 | 1994 | 17 | 0.060 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2005 | 165 | 0.060 |
Why?
|
| Ruminococcus | 2 | 2015 | 11 | 0.060 |
Why?
|
| Heartburn | 1 | 2023 | 19 | 0.060 |
Why?
|
| Lactic Acid | 3 | 1994 | 305 | 0.060 |
Why?
|
| Physicians | 1 | 2012 | 882 | 0.060 |
Why?
|
| Random Allocation | 3 | 1994 | 703 | 0.060 |
Why?
|
| Psychometrics | 2 | 2021 | 937 | 0.060 |
Why?
|
| Magnesium | 2 | 2022 | 160 | 0.060 |
Why?
|
| Infusions, Intravenous | 3 | 1999 | 1382 | 0.060 |
Why?
|
| Perfusion | 1 | 2005 | 293 | 0.060 |
Why?
|
| Catheterization | 1 | 1986 | 410 | 0.060 |
Why?
|
| Drinking | 1 | 2023 | 54 | 0.060 |
Why?
|
| Nursing Assessment | 1 | 2003 | 42 | 0.060 |
Why?
|
| Hypoglycemia | 1 | 1985 | 213 | 0.060 |
Why?
|
| Edible Grain | 1 | 1983 | 54 | 0.060 |
Why?
|
| Psychology, Child | 1 | 2003 | 43 | 0.060 |
Why?
|
| Nurse's Role | 1 | 2003 | 42 | 0.060 |
Why?
|
| Health Surveys | 2 | 2018 | 402 | 0.060 |
Why?
|
| Basal Metabolism | 1 | 2003 | 88 | 0.060 |
Why?
|
| Pediatric Nursing | 1 | 2003 | 38 | 0.060 |
Why?
|
| Potassium | 2 | 2022 | 329 | 0.060 |
Why?
|
| Vitamin E | 2 | 2022 | 136 | 0.060 |
Why?
|
| Epinephrine | 2 | 2001 | 255 | 0.050 |
Why?
|
| Dietary Fats | 2 | 1994 | 339 | 0.050 |
Why?
|
| Nutritional Support | 1 | 2023 | 80 | 0.050 |
Why?
|
| Vitamin B 6 | 1 | 2022 | 19 | 0.050 |
Why?
|
| Thiamine | 1 | 2022 | 11 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 1983 | 95 | 0.050 |
Why?
|
| Registries | 2 | 2021 | 2170 | 0.050 |
Why?
|
| Osteomalacia | 1 | 2002 | 36 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2015 | 1053 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 1489 | 0.050 |
Why?
|
| Models, Chemical | 2 | 1997 | 186 | 0.050 |
Why?
|
| Vitamin D | 2 | 2022 | 261 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2018 | 11965 | 0.050 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2022 | 46 | 0.050 |
Why?
|
| Critical Illness | 2 | 2023 | 714 | 0.050 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 46 | 0.050 |
Why?
|
| National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2021 | 9 | 0.050 |
Why?
|
| CD56 Antigen | 1 | 2021 | 83 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2022 | 131 | 0.050 |
Why?
|
| Linear Models | 2 | 2016 | 1085 | 0.050 |
Why?
|
| Fasting | 2 | 1991 | 349 | 0.050 |
Why?
|
| Interstitial Cells of Cajal | 1 | 2021 | 3 | 0.050 |
Why?
|
| Homeostasis | 2 | 2010 | 950 | 0.050 |
Why?
|
| United Kingdom | 1 | 2021 | 257 | 0.050 |
Why?
|
| Birth Weight | 3 | 1999 | 374 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1983 | 675 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2002 | 115 | 0.050 |
Why?
|
| Phosphocreatine | 3 | 1996 | 17 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2001 | 145 | 0.050 |
Why?
|
| Norepinephrine | 1 | 2001 | 272 | 0.050 |
Why?
|
| Hyperammonemia | 1 | 2001 | 68 | 0.050 |
Why?
|
| Cholic Acids | 1 | 2020 | 30 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 543 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 159 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 397 | 0.050 |
Why?
|
| Contraindications | 1 | 2000 | 150 | 0.050 |
Why?
|
| Mass Screening | 1 | 2009 | 1509 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2021 | 264 | 0.050 |
Why?
|
| Trace Elements | 1 | 2000 | 33 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 7222 | 0.050 |
Why?
|
| Treatment Failure | 2 | 2005 | 1391 | 0.050 |
Why?
|
| Complement C2 | 1 | 2019 | 2 | 0.050 |
Why?
|
| Dopamine | 1 | 2001 | 312 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2000 | 157 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2002 | 241 | 0.040 |
Why?
|
| Algorithms | 1 | 2010 | 3890 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2021 | 492 | 0.040 |
Why?
|
| Carbon | 2 | 1994 | 149 | 0.040 |
Why?
|
| Equipment Failure | 2 | 2011 | 191 | 0.040 |
Why?
|
| Liver Glycogen | 2 | 1991 | 31 | 0.040 |
Why?
|
| Aging | 3 | 1998 | 1582 | 0.040 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 183 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2021 | 556 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 2483 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 4938 | 0.040 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2019 | 215 | 0.040 |
Why?
|
| Aspartic Acid | 2 | 1992 | 126 | 0.040 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 1999 | 83 | 0.040 |
Why?
|
| Safety | 1 | 2000 | 465 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 577 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 2019 | 101 | 0.040 |
Why?
|
| Food Labeling | 1 | 2018 | 11 | 0.040 |
Why?
|
| Oxidation-Reduction | 3 | 1986 | 717 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2018 | 103 | 0.040 |
Why?
|
| Disease Progression | 2 | 2014 | 6682 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 4971 | 0.040 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 889 | 0.040 |
Why?
|
| Atrophy | 3 | 2012 | 261 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 396 | 0.040 |
Why?
|
| Astrocytes | 1 | 2001 | 368 | 0.040 |
Why?
|
| Lipids | 2 | 2000 | 644 | 0.040 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 1997 | 15 | 0.040 |
Why?
|
| Muscle Contraction | 2 | 1996 | 218 | 0.040 |
Why?
|
| Anaerobiosis | 2 | 1987 | 21 | 0.040 |
Why?
|
| Aerobiosis | 2 | 1987 | 30 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 717 | 0.040 |
Why?
|
| Cimetidine | 1 | 1996 | 28 | 0.040 |
Why?
|
| Ranitidine | 1 | 1996 | 35 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 224 | 0.040 |
Why?
|
| Nucleotides | 2 | 1989 | 164 | 0.040 |
Why?
|
| Africa | 1 | 2016 | 142 | 0.040 |
Why?
|
| Anthelmintics | 1 | 2016 | 69 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 750 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 597 | 0.040 |
Why?
|
| Anti-Ulcer Agents | 1 | 1996 | 101 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2019 | 4298 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 344 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1998 | 333 | 0.030 |
Why?
|
| Vitamin A | 2 | 2014 | 94 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Calcium, Dietary | 1 | 1996 | 56 | 0.030 |
Why?
|
| Chromatography | 1 | 1995 | 49 | 0.030 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2015 | 21 | 0.030 |
Why?
|
| Child Health Services | 1 | 2016 | 82 | 0.030 |
Why?
|
| Environment | 1 | 2016 | 190 | 0.030 |
Why?
|
| Gammaproteobacteria | 1 | 2015 | 19 | 0.030 |
Why?
|
| Lung | 1 | 1987 | 3151 | 0.030 |
Why?
|
| Cognition | 1 | 1982 | 968 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.030 |
Why?
|
| Bacillus | 1 | 2015 | 37 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1995 | 220 | 0.030 |
Why?
|
| Social Class | 1 | 2017 | 310 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1999 | 473 | 0.030 |
Why?
|
| Urinalysis | 1 | 1995 | 84 | 0.030 |
Why?
|
| Staphylococcal Infections | 2 | 1994 | 672 | 0.030 |
Why?
|
| Logistic Models | 2 | 2017 | 3441 | 0.030 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2015 | 94 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2016 | 281 | 0.030 |
Why?
|
| Corn Oil | 1 | 1994 | 15 | 0.030 |
Why?
|
| Fats | 1 | 1994 | 16 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1996 | 553 | 0.030 |
Why?
|
| Membrane Lipids | 1 | 1994 | 48 | 0.030 |
Why?
|
| Recommended Dietary Allowances | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sialorrhea | 1 | 2014 | 17 | 0.030 |
Why?
|
| Polysomnography | 1 | 2015 | 155 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 94 | 0.030 |
Why?
|
| C-Peptide | 1 | 1994 | 107 | 0.030 |
Why?
|
| Spices | 1 | 2013 | 5 | 0.030 |
Why?
|
| Fish Oils | 1 | 2014 | 88 | 0.030 |
Why?
|
| Staphylococcus | 1 | 1994 | 86 | 0.030 |
Why?
|
| Bilirubin | 2 | 2005 | 221 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2014 | 79 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1994 | 159 | 0.030 |
Why?
|
| Bicarbonates | 2 | 1984 | 130 | 0.030 |
Why?
|
| Dipeptides | 1 | 1994 | 91 | 0.030 |
Why?
|
| Anthropometry | 1 | 2015 | 269 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 100 | 0.030 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2014 | 92 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2014 | 356 | 0.030 |
Why?
|
| Allergens | 1 | 2015 | 247 | 0.030 |
Why?
|
| Somatostatin | 1 | 1994 | 114 | 0.030 |
Why?
|
| Nerve Fibers | 1 | 2013 | 106 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2013 | 32 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2019 | 1048 | 0.030 |
Why?
|
| Risk | 3 | 1987 | 1972 | 0.030 |
Why?
|
| Focus Groups | 1 | 2013 | 256 | 0.030 |
Why?
|
| Drinking Water | 1 | 2012 | 21 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 1304 | 0.030 |
Why?
|
| Gelsolin | 1 | 2012 | 14 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1992 | 66 | 0.030 |
Why?
|
| Bone Diseases, Metabolic | 1 | 1993 | 84 | 0.030 |
Why?
|
| Erythrocytes | 2 | 1992 | 339 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 3869 | 0.030 |
Why?
|
| Pandemics | 1 | 2022 | 1559 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 1682 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2015 | 4744 | 0.030 |
Why?
|
| Behavior | 1 | 2012 | 103 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 2218 | 0.030 |
Why?
|
| Creatine | 1 | 1992 | 61 | 0.030 |
Why?
|
| Radiography | 2 | 2015 | 1904 | 0.030 |
Why?
|
| Dextran Sulfate | 1 | 2012 | 72 | 0.030 |
Why?
|
| Mast Cells | 1 | 2013 | 223 | 0.030 |
Why?
|
| Haemophilus parainfluenzae | 1 | 2011 | 10 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1989 | 410 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 342 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 217 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1992 | 682 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2014 | 498 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 1991 | 121 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 590 | 0.020 |
Why?
|
| Ligation | 1 | 1991 | 193 | 0.020 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1992 | 108 | 0.020 |
Why?
|
| RNA | 3 | 1992 | 1013 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1992 | 269 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 1996 | 731 | 0.020 |
Why?
|
| Species Specificity | 1 | 2012 | 777 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2014 | 667 | 0.020 |
Why?
|
| Calcium | 2 | 1994 | 1537 | 0.020 |
Why?
|
| Isoenzymes | 1 | 1992 | 614 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 368 | 0.020 |
Why?
|
| Duodenum | 2 | 1988 | 149 | 0.020 |
Why?
|
| Neurons | 1 | 2001 | 2287 | 0.020 |
Why?
|
| Respiration | 3 | 2007 | 447 | 0.020 |
Why?
|
| Reference Values | 2 | 2006 | 1099 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 4549 | 0.020 |
Why?
|
| Body Weight | 2 | 1999 | 1293 | 0.020 |
Why?
|
| Xylose | 1 | 1989 | 19 | 0.020 |
Why?
|
| Tropical Climate | 1 | 2009 | 51 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2013 | 764 | 0.020 |
Why?
|
| Pamphlets | 1 | 1989 | 31 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 1986 | 4557 | 0.020 |
Why?
|
| Chemical Precipitation | 1 | 1988 | 23 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2014 | 2292 | 0.020 |
Why?
|
| Calcium Gluconate | 1 | 1988 | 7 | 0.020 |
Why?
|
| DNA | 4 | 1992 | 2693 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1988 | 34 | 0.020 |
Why?
|
| Child, Hospitalized | 1 | 1989 | 62 | 0.020 |
Why?
|
| Emotions | 1 | 2012 | 562 | 0.020 |
Why?
|
| Solubility | 1 | 1988 | 242 | 0.020 |
Why?
|
| Iodoacetic Acid | 1 | 1987 | 3 | 0.020 |
Why?
|
| Sugar Phosphates | 1 | 1987 | 4 | 0.020 |
Why?
|
| Genomics | 1 | 2019 | 2738 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 418 | 0.020 |
Why?
|
| Pregnancy | 2 | 1998 | 7573 | 0.020 |
Why?
|
| Developing Countries | 1 | 2010 | 315 | 0.020 |
Why?
|
| Epithelium | 1 | 1990 | 720 | 0.020 |
Why?
|
| Electrolytes | 2 | 1986 | 68 | 0.020 |
Why?
|
| Body Water | 2 | 1986 | 132 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1989 | 684 | 0.020 |
Why?
|
| Asthma | 1 | 2015 | 871 | 0.020 |
Why?
|
| Incidence | 2 | 2011 | 5673 | 0.020 |
Why?
|
| Hair Color | 1 | 1986 | 20 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1989 | 665 | 0.020 |
Why?
|
| Hypoxia, Brain | 1 | 1986 | 31 | 0.020 |
Why?
|
| Skin Diseases, Infectious | 1 | 1987 | 22 | 0.020 |
Why?
|
| Peptides | 1 | 2012 | 1479 | 0.020 |
Why?
|
| Etoposide | 1 | 1988 | 870 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1987 | 401 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 1130 | 0.020 |
Why?
|
| Protons | 1 | 1989 | 473 | 0.020 |
Why?
|
| Energy Transfer | 1 | 1985 | 35 | 0.020 |
Why?
|
| Computational Biology | 1 | 2012 | 1271 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 2005 | 45 | 0.020 |
Why?
|
| Cholagogues and Choleretics | 1 | 2005 | 33 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1996 | 1362 | 0.020 |
Why?
|
| Duodenal Ulcer | 1 | 1986 | 113 | 0.020 |
Why?
|
| Immunoelectrophoresis, Two-Dimensional | 1 | 1985 | 12 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1985 | 46 | 0.020 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1985 | 10 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1989 | 383 | 0.020 |
Why?
|
| Fatty Liver | 1 | 1987 | 235 | 0.020 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1985 | 41 | 0.020 |
Why?
|
| Rabbits | 1 | 1986 | 957 | 0.020 |
Why?
|
| Acute Disease | 1 | 1990 | 2422 | 0.020 |
Why?
|
| Software | 1 | 2012 | 1321 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1989 | 615 | 0.020 |
Why?
|
| Neoplasms | 2 | 1988 | 15193 | 0.020 |
Why?
|
| Pulmonary Veins | 1 | 1987 | 174 | 0.020 |
Why?
|
| Glycolysis | 1 | 1987 | 519 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 568 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1986 | 931 | 0.020 |
Why?
|
| Sepsis | 2 | 1987 | 652 | 0.020 |
Why?
|
| Triglycerides | 1 | 1987 | 603 | 0.020 |
Why?
|
| Skin Ulcer | 1 | 1984 | 77 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 1989 | 748 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2006 | 482 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1992 | 3154 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 1986 | 264 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1983 | 116 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 945 | 0.010 |
Why?
|
| Hormones | 1 | 1984 | 266 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 2291 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 7702 | 0.010 |
Why?
|
| Problem Solving | 1 | 1982 | 85 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 2002 | 118 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2006 | 358 | 0.010 |
Why?
|
| Intelligence | 1 | 1982 | 126 | 0.010 |
Why?
|
| Electroencephalography | 1 | 1985 | 898 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1982 | 233 | 0.010 |
Why?
|
| Phenotype | 1 | 2011 | 6295 | 0.010 |
Why?
|
| Obesity | 1 | 2012 | 2884 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 1984 | 769 | 0.010 |
Why?
|
| Mitochondria | 1 | 1985 | 1282 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 1544 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2005 | 1863 | 0.010 |
Why?
|
| Glucosephosphates | 1 | 1996 | 5 | 0.010 |
Why?
|
| Glucose-6-Phosphate | 1 | 1996 | 14 | 0.010 |
Why?
|
| Ileostomy | 1 | 1997 | 46 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1996 | 55 | 0.010 |
Why?
|
| Organic Chemicals | 2 | 1986 | 113 | 0.010 |
Why?
|
| Microvilli | 1 | 1994 | 83 | 0.010 |
Why?
|
| Triiodothyronine | 1 | 1994 | 77 | 0.010 |
Why?
|
| Coagulase | 1 | 1994 | 29 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1994 | 60 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1994 | 95 | 0.010 |
Why?
|
| Phospholipids | 1 | 1994 | 177 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 1993 | 56 | 0.010 |
Why?
|
| Sodium | 1 | 1994 | 353 | 0.010 |
Why?
|
| Thyroxine | 1 | 1992 | 116 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1994 | 842 | 0.010 |
Why?
|
| Heart Failure | 1 | 2006 | 2516 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1994 | 448 | 0.010 |
Why?
|
| Cholesterol | 1 | 1994 | 658 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 34495 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 1062 | 0.010 |
Why?
|
| Bone Density | 1 | 1993 | 476 | 0.010 |
Why?
|
| Organ Size | 1 | 1991 | 690 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2002 | 6869 | 0.010 |
Why?
|
| Consumer Behavior | 1 | 1989 | 46 | 0.010 |
Why?
|
| Protein-Energy Malnutrition | 1 | 1988 | 73 | 0.000 |
Why?
|
| Hydroxycholecalciferols | 1 | 1986 | 13 | 0.000 |
Why?
|
| Kidney | 1 | 1994 | 2146 | 0.000 |
Why?
|
| Cerebral Hemorrhage | 1 | 1986 | 183 | 0.000 |
Why?
|
| Esophagitis | 1 | 1986 | 202 | 0.000 |
Why?
|
| Alanine | 1 | 1985 | 240 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1984 | 191 | 0.000 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1986 | 137 | 0.000 |
Why?
|
| Isotope Labeling | 1 | 1984 | 142 | 0.000 |
Why?
|
| Sodium Bicarbonate | 1 | 1984 | 59 | 0.000 |
Why?
|
| Mouth Diseases | 1 | 1984 | 34 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1986 | 186 | 0.000 |
Why?
|
| Ulcer | 1 | 1984 | 78 | 0.000 |
Why?
|
| Mathematics | 1 | 1983 | 136 | 0.000 |
Why?
|
| Portal Vein | 1 | 1985 | 355 | 0.000 |
Why?
|
| Proteins | 1 | 1991 | 1963 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 8865 | 0.000 |
Why?
|
| Muscle Proteins | 1 | 1986 | 549 | 0.000 |
Why?
|